LAUSR

About LAUSR
Donate
Contact Us

Follow us:

You are not signed in:

Sign Up!


   Articles with "east afnet" as a keyword



Blood-based cardiometabolic phenotypes in atrial fibrillation and their associated risk: EAST-AFNET 4 biomolecule study

Sign Up to like & get
recommendations! Published in 2024 at "Cardiovascular Research"

DOI: 10.1093/cvr/cvae067

Abstract: Abstract Aims Atrial fibrillation (AF) and concomitant cardiometabolic disease processes interact and combine to lead to adverse events, such as stroke, heart failure, myocardial infarction, and cardiovascular death. Circulating biomolecules provide quantifiable proxies for cardiometabolic… read more here.

Keywords: cluster; risk; biomolecule; east afnet ... See more keywords

Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST-AFNET 4 trial

Sign Up to like & get
recommendations! Published in 2022 at "European Heart Journal"

DOI: 10.1093/eurheartj/ehac471

Abstract: Abstract Aims A strategy of systematic, early rhythm control (ERC) improves cardiovascular outcomes in patients with atrial fibrillation (AF). It is not known how this outcome-reducing effect is mediated. Methods and results Using the Early… read more here.

Keywords: rhythm control; early rhythm; rhythm; east afnet ... See more keywords

Safety and efficacy of long-term sodium channel blocker therapy for early rhythm control: the EAST-AFNET 4 trial

Sign Up to like & get
recommendations! Published in 2024 at "Europace"

DOI: 10.1093/europace/euae102.078

Abstract: Abstract Background Clinical concerns exist about the potential proarrhythmic effects of the sodium channel blockers flecainide and propafenone (SCB) in patients with cardiovascular disease. Purpose SCB were used to deliver early rhythm control (ERC) therapy… read more here.

Keywords: rhythm control; safety; east afnet; therapy ... See more keywords

Rate versus rhythm control for atrial fibrillation: from AFFIRM to EAST-AFNET 4 - a paradigm shift.

Sign Up to like & get
recommendations! Published in 2022 at "Future cardiology"

DOI: 10.2217/fca-2021-0034

Abstract: The clinical choice between rate or rhythm control therapies has been debated over the years. In 2002, the AFFIRM trial demonstrated that the rhythm-control strategy had no survival advantage over the rate-control strategy. Eighteen years… read more here.

Keywords: rhythm control; control; east afnet; rate ... See more keywords